Kidney research study now enrolling. If you are living with moderate to advanced chronic kidney disease (CKD) and high blood pressure, you may be eligible to participate in research that explores the efficacy of a potential medicine

If you’re taking TARPEYO® (budesonide) delayed release capsules and coming to the end of your 9-month treatment course, a new clinical study may be a potential option for you. The NefXtend Study is being conducted by Apex Clinical Research of Georgia to evaluate a 15-month treatment extension of TARPEYO®.